AstraZeneca is a global healthcare company active in more than 100 countries. Its main activities involve the research, development, manufacture and marketing of prescription pharmaceuticals. Headquartered in London, with major research and development sites in the UK, US and Sweden, the company employs over 66,000 people in 20 countries, with 2006 sales totaling $26.5 billion. AstraZeneca has 26 manufacturing sites in 19 countries, and through this manufacturing process is a major consumer of

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to View our subscription options

If you already have an account, please sign in here.

Counting down to dollar Libor transition

In a webinar, experts discussed the impact of market volatility on Libor transition, the availability of term SOFR, developments in non-linear markets and management of forthcoming CCP conversions

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here